Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination release_4rsdu555cjhopoibkkykp6pt2y

by Roberta Pastorino, Angelo Maria Pezzullo, Leonardo Villani, Francesco Andrea Causio, Cathrine Axfors, Despina G. Contopoulos-Ioannidis, Stefania Boccia, John Ioannidis

Published in Environmental Research by Elsevier BV.

2021   p112342

Abstract

Most countries initially deployed COVID-19 vaccines preferentially in elderly populations. We aimed to evaluate whether population-level vaccine effectiveness is heralded by an increase in the relative proportion of deaths among non-elderly populations that were less covered by vaccination programs. We collected data from 40 countries on age-stratified COVID-19 deaths during the vaccination period (1/14/2021-5/31/2021) and two control periods (entire pre-vaccination period and excluding the first wave). We meta-analyzed the proportion of deaths in different age groups in vaccination versus control periods in countries with low vaccination rates; (2) countries with age-independent vaccination policies; and (3) countries with standard age-dependent vaccination policies. Countries that prioritized vaccination among older people saw an increasing share of deaths among 0-69 year old people in the vaccination versus the two control periods (summary proportion ratio 1.32 [95 CI% 1.24-1.41] and 1.35 [95 CI% 1.26-1.44)]. No such change was seen on average in countries with age-independent vaccination policies (1.05 [95 CI% 0.78-1.41 and 0.97 [95 CI% 0.95-1.00], respectively) and limited vaccination (0.93 [95 CI% 0.85-1.01] and 0.95 [95 CI% 0.87-1.03], respectively). Proportion ratios were associated with the difference of vaccination rates in elderly versus non-elderly people. No significant changes occurred in the share of deaths in age 0-49 among all 0-69 deaths in the vaccination versus pre-vaccination periods. The substantial shift in the age distribution of COVID-19 deaths in countries that rapidly implemented vaccination predominantly among elderly provides evidence for the population level-effectiveness of COVID-19 vaccination and a favorable evolution of the pandemic towards endemicity with fewer elderly deaths.
In text/plain format

Archived Files and Locations

There are no accessible files associated with this release. You could check other releases for this work for an accessible version.

"Dark" Archived
Save Paper Now!

Know of a fulltext copy of on the public web? Submit a URL and we will archive it

Type  article-journal
Stage   published
Date   2021-11-05
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registery
ISSN-L:  0013-9351
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 101d1936-f83b-4f2b-b064-c7d3a7c13453
API URL: JSON